These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 22258159)

  • 1. Myotonic dystrophy type 2 is rare in the Japanese population.
    Matsuura T; Minami N; Arahata H; Ohno K; Abe K; Hayashi YK; Nishino I
    J Hum Genet; 2012 Mar; 57(3):219-20. PubMed ID: 22258159
    [No Abstract]   [Full Text] [Related]  

  • 2. Severe dilated cardiomyopathy in a patient with myotonic dystrophy type 2 and homozygous repeat expansion in ZNF9.
    Lee TM; Maurer MS; Karbassi I; Braastad C; Batish SD; Chung WK
    Congest Heart Fail; 2012; 18(3):183-6. PubMed ID: 22587749
    [No Abstract]   [Full Text] [Related]  

  • 3. [Myotonic dystrophy type 2].
    Kimura T; Saito T
    Brain Nerve; 2011 Nov; 63(11):1151-60. PubMed ID: 22068467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myotonic syndromes.
    Mankodi A; Thornton CA
    Curr Opin Neurol; 2002 Oct; 15(5):545-52. PubMed ID: 12351998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The unstable CCTG repeat responsible for myotonic dystrophy type 2 originates from an AluSx element insertion into an early primate genome.
    Kurosaki T; Ueda S; Ishida T; Abe K; Ohno K; Matsuura T
    PLoS One; 2012; 7(6):e38379. PubMed ID: 22723857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myotonic dystrophy: clinical and molecular parallels between myotonic dystrophy type 1 and type 2.
    Ranum LP; Day JW
    Curr Neurol Neurosci Rep; 2002 Sep; 2(5):465-70. PubMed ID: 12169228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of the diagnostic procedure in proximal myotonic myopathy/myotonic dystrophy type 2.
    Jakubiczka S; Vielhaber S; Kress W; Küpferling P; Reuner U; Kunath B; Wieacker P
    Neurogenetics; 2004 Feb; 5(1):55-9. PubMed ID: 14666402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myotonic dystrophy type 2 in Japan: ancestral origin distinct from Caucasian families.
    Saito T; Amakusa Y; Kimura T; Yahara O; Aizawa H; Ikeda Y; Day JW; Ranum LP; Ohno K; Matsuura T
    Neurogenetics; 2008 Feb; 9(1):61-3. PubMed ID: 18057971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An expansion in the ZNF9 gene causes PROMM in a previously described family with an incidental CLCN1 mutation.
    Lamont PJ; Jacob RL; Mastaglia FL; Laing NG
    J Neurol Neurosurg Psychiatry; 2004 Feb; 75(2):343. PubMed ID: 14742629
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical and genetic analysis of a family with PROMM.
    Grewal RP; Zhang S; Ma W; Rosenberg M; Krahe R
    J Clin Neurosci; 2004 Aug; 11(6):603-5. PubMed ID: 15261229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The myotonic dystrophies: molecular, clinical, and therapeutic challenges.
    Udd B; Krahe R
    Lancet Neurol; 2012 Oct; 11(10):891-905. PubMed ID: 22995693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Best practice guidelines and recommendations on the molecular diagnosis of myotonic dystrophy types 1 and 2.
    Kamsteeg EJ; Kress W; Catalli C; Hertz JM; Witsch-Baumgartner M; Buckley MF; van Engelen BG; Schwartz M; Scheffer H
    Eur J Hum Genet; 2012 Dec; 20(12):1203-8. PubMed ID: 22643181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myotonic dystrophy type 2 and related myotonic disorders.
    Meola G; Moxley RT
    J Neurol; 2004 Oct; 251(10):1173-82. PubMed ID: 15503094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutant (CCTG)n expansion causes abnormal expression of zinc finger protein 9 (ZNF9) in myotonic dystrophy type 2.
    Raheem O; Olufemi SE; Bachinski LL; Vihola A; Sirito M; Holmlund-Hampf J; Haapasalo H; Li YP; Udd B; Krahe R
    Am J Pathol; 2010 Dec; 177(6):3025-36. PubMed ID: 20971734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myotonia congenita and myotonic dystrophy in the same family: coexistence of a CLCN1 mutation and expansion in the CNBP (ZNF9) gene.
    Sun C; Van Ghelue M; Tranebjærg L; Thyssen F; Nilssen Ø; Torbergsen T
    Clin Genet; 2011 Dec; 80(6):574-80. PubMed ID: 21204798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Molecular and genetic aspects of the myotonic conditions].
    Morales Montero F; Cuenca Berger P
    Rev Neurol; 2004 Apr 1-15; 38(7):668-74. PubMed ID: 15098190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absent, unrecognized, and minimal myotonic discharges in myotonic dystrophy type 2.
    Young NP; Daube JR; Sorenson EJ; Milone M
    Muscle Nerve; 2010 Jun; 41(6):758-62. PubMed ID: 20513102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-segregation of DM2 with a recessive CLCN1 mutation in juvenile onset of myotonic dystrophy type 2.
    Cardani R; Giagnacovo M; Botta A; Rinaldi F; Morgante A; Udd B; Raheem O; Penttilä S; Suominen T; Renna LV; Sansone V; Bugiardini E; Novelli G; Meola G
    J Neurol; 2012 Oct; 259(10):2090-9. PubMed ID: 22407275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myotonic dystrophies.
    Meola G
    Curr Opin Neurol; 2000 Oct; 13(5):519-25. PubMed ID: 11073357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Recommendations of good practices for the genetic diagnosis of myotonic dystrophy. Grupo AEGH/CIBERER].
    Garcia Planells J; Molano J; Borrego S;
    Med Clin (Barc); 2011 Mar; 136(7):303-8. PubMed ID: 20863536
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.